ArticleScientific reports2023

Neoadjuvant chemotherapy reduces the levels of HMGB1 and E-cadherin in patients with breast cancer.

Qingchang Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.